What is Latisse?
Full, natural-looking eyelashes can now be achieved through a prescription treatment called Latisse™. Women who want eyelash extensions in New Jersey use Latisse, the first and only eyelash treatment approved by the FDA to help grow longer, fuller and darker eyelashes and treat hypotrichosis, a condition that includes having inadequate or not enough eyelashes.
If you’ve been considering LATISSE®, please request a consultation online, or call Dr. Schrader’s office at 609-279-0009.
Latisse contains bimatoprost, an active ingredient that improves the appearance of your lashes and is often found in glaucoma medication. While the precise science of the treatment is not known, research suggests that the number of hairs and duration of the growth process are increased by bimatoprost.
This prescription medication is applied topically to the base of the eyelashes once a day, after makeup and contact lenses have been removed and any other skincare products have already been applied. While it does not replace mascara, LATISSE® offers an attractive complement to help further enhance full, long and beautiful lashes.
Take a moment to assess your lashes. Perhaps you’ve noticed a change in your lashes over the years. Have they lost their fullness? Do they appear shorter? Or lighter in color? If so, it’s time to consider LATISSE® – the only FDA-approved product that grows lashes, increasing their overall prominence.
The results of LATISSE® are visible after 4 weeks, with full results appearing after 16 weeks. You can track the progress of your results through photographs. Side effects of Latisse are rare but may include itching, redness or dryness in the eye area. You should not use LATISSE® if you have an active eye infection or broken skin or irritated skin on the eyelid. Call your doctor today to find out if LATISSE® is right for you.
LATISSE® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
You may be surprised to know that published expert opinions have linked thinning and loss of eyelashes to aging. This finding led Allergan to analyze the photos of a subset of women with inadequate or not enough lashes pooled from three LATISSE® clinical trials. The results revealed that the older women had thinner, shorter and lighter lashes at week 0, compared to the younger women in the trials. The demographic data suggests there may be a downward trend of eyelash fullness, length and darkness as women with inadequate lashes age.
LATISSE® can grow thinning lashes. In the US Phase III LATISSE® clinical trial, 91% of women participating (n=134) were 35 or older, and results show that LATISSE® more than doubled lash fullness after 16 weeks of treatment for these patients.
Dr. Schrader has 20 years experience, over 15 years in private practice in the Pennsylvania area and performed hundreds of LATISSE® and other cosmetic procedures.
- Is trained and experienced in all facial plastic surgery procedures
- Operates only in accredited medical facilities
- Adheres to a strict code of ethics
- Is board certified by The American Board of Facial Plastic and Reconstructive Surgery (AAFPRS)
Click here to request your consultation with Dr. Schrader.